fbpx

Health Care

The Helena Theurer Pavilion is a new, nine-story, 530,000-square-foot surgical and intensive care tower at Hackensack University Medical Center.

Hackensack University Medical Center 1st in NJ to use da Vinci 5 robotic system

"The da Vinci 5 represents the next chapter in our robotic surgery journey, and we are proud to be among the first in the world to offer this game-changing robotic surgery option to our patients,” said Hackensack Meridian Health CEO Robert Garrett.

Pregnant woman on cellphone

3 NJ hospitals recognized for Black maternal health care

Only 26 facilities nationwide made the U.S. News & World Report list, which was released at the start of Black Maternal Health Week.

Located on Winters Avenue, the 370-bed, 910,000-square-foot Valley Hospital in Paramus is the centerpiece of a 40-acre campus that unites acute inpatient care with the network’s wide range of outpatient services.

Valley completes move into new Paramus hospital

Over the course of seven hours, 203 patients admitted to the previous Valley Hospital were individually transported by 75 ambulances to the new facility.

Stethoscope on money

NJ cardiologist pleads guilty to $1.9M health care fraud scheme

“Dr. Panezai successfully ran a very busy medical practice for decades in which he went above and beyond for his patients,” the defendant's attorney told NJBIZ. “Nevertheless, Dr. Panezai regrets his billing transgressions.”

New Jersey Economic Development Authority CEO Tim Sullivan speaks during a Jan. 20, 2023, event in North Brunswick.

Trenton Maternal and Infant Health Innovation Center takes next steps

Rutgers University, Capital Health and Trenton Health Team will serve as anchor tenants at the developing $75 million hub.

Pharmacy

OPINION: Unintended barriers

The executive director of Patients Come First New Jersey writes, "It’s unfortunate that today’s health care system often prioritizes the desires of special interests over ensuring that patients have access to the advanced and innovative medical care available in our system."

Neutrogena is a skin care brand of parent company Kenvue.

Kenvue to relocate Neutrogena from California to NJ

The skin care brand is closing its Los Angeles headquarters as its parent company, a spinoff of Johnson & Johnson, consolidates operations to Summit.

AtlantiCare’s transformative 6-year plan includes a med school, AI and high-profile partnerships

To achieve its goals of establishing a forward-thinking health care destination, the 125-year-old system is enlisting partners, including Cleveland Clinic Cancer Institute, Drexel University College of Medicine, Oracle Health and Global Neurosciences Institute.

Dr. Jaffar Raza, an interventional cardiologist at Holy Name, performed the first ultrasound renal denervation procedure in New Jersey.

Holy Name performs innovative blood pressure, spinal procedures

The Teaneck-based provider said it completed New Jersey's first ultrasound renal denervation procedure and is now one of only a few hospitals in the Garden State to use Globus Medical’s ExcelsiusGPS system.

Mental health contept and brain disorder awareness as a healthcare or health care concept with 3D illustration elements.

Hackensack Meridian researchers receive $2.2M federal grant

The five-year award will fund research looking at a novel treatment for traumatic brain injuries, the Edison facility announced April 9.

Robin Ferrer has been named chief nursing officer for Cooperman Barnabas Medical Center in Livingston, part of RWJBarnabas Health.

Former Mount Sinai VP named Cooperman Barnabas CNO

In his previous position, Robin Ferrer served as vice president of health system's Emergency Services for three years, overseeing seven departments. 

The New York Stock Exchange welcomed Johnson & Johnson to ring the Opening Bell on Dec. 5, 2023, as part of the company's celebration of the 80th anniversary of its "Our Credo." J&J Chairman and CEO Joaquin Duato, as well as several J&J employees, joined Lynn Martin, NYSE president, for the honor.

J&J to acquire Shockwave Medical for $13.1B

The move extends Johnson & Johnson MedTech's position in cardiovascular intervention while also positioning it into higher-growth markets.